Literature DB >> 23270554

Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science).

Derek J Hausenloy1.   

Abstract

Ischemic heart disease (IHD) is the leading cause of death and disability worldwide. The major pathological consequences of IHD arise from the detrimental effects of acute ischemia-reperfusion injury (IRI) on the myocardium. Therefore, in order to improve clinical outcomes in patients with IHD, novel therapeutic strategies are required to protect the myocardium from acute IRI and preserve cardiac function (cardioprotection). In this regard, endogenous cardioprotective strategies such as ischemic preconditioning (IPC), ischemic postconditioning (IPost) and remote ischemic conditioning (RIC) may provide novel approaches for protecting the heart in clinical settings in which the patient experiences acute myocardial IRI. In this review article, we provide an overview of these endogenous cardioprotective strategies with respect to the pre-clinical experimental literature, exploring their major characteristics and underlying signaling mechanisms. The application of these therapeutic strategies in the clinical setting for potential patient benefit is reviewed in another article in this special issue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23270554     DOI: 10.2174/1381612811319250004

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  33 in total

1.  At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.

Authors:  Defeng Pan; Dongye Li
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  Myocardial remote ischemic preconditioning: from cell biology to clinical application.

Authors:  Martín Donato; Ricardo J Gelpi; Eliana P Bin; Verónica D Annunzio
Journal:  Mol Cell Biochem       Date:  2021-06-14       Impact factor: 3.396

Review 3.  Remote ischemic preconditioning for myocardial protection: update on mechanisms and clinical relevance.

Authors:  Rabia Gill; Robin Kuriakose; Zachary M Gertz; Fadi N Salloum; Lei Xi; Rakesh C Kukreja
Journal:  Mol Cell Biochem       Date:  2015-01-01       Impact factor: 3.396

4.  Optimizing cardiac ischemic preconditioning and postconditioning via epitranscriptional regulation.

Authors:  Richa Saxena; Neal L Weintraub; Yaoliang Tang
Journal:  Med Hypotheses       Date:  2019-10-24       Impact factor: 1.538

5.  AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling.

Authors:  Qutuba G Karwi; Julia Bornbaum; Kerstin Boengler; Roberta Torregrossa; Matthew Whiteman; Mark E Wood; Rainer Schulz; Gary F Baxter
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

6.  New Developments in Cardiac Arrest Management.

Authors:  Matthias L Riess
Journal:  Adv Anesth       Date:  2016

7.  Metformin in Diabetic Patients with Heart Failure: Safe and Effective?

Authors:  Ijeoma Ananaba Ekeruo; Amirreza Solhpour; Heinrich Taegtmeyer
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

8.  Anti-necrotic and cardioprotective effects of a cytosolic renin isoform under ischemia-related conditions.

Authors:  Heike Wanka; Doreen Staar; Philipp Lutze; Barbara Peters; Johanna Hildebrandt; Tim Beck; Inga Bäumgen; Alexander Albers; Thomas Krieg; Katrin Zimmermann; Jaroslaw Sczodrok; Simon Schäfer; Sigrid Hoffmann; Jörg Peters
Journal:  J Mol Med (Berl)       Date:  2015-08-11       Impact factor: 4.599

Review 9.  Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.

Authors:  Alexander T Akhmedov; Vitalyi Rybin; José Marín-García
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

10.  Left Ventricular Unloading Before Reperfusion Promotes Functional Recovery After Acute Myocardial Infarction.

Authors:  Michele L Esposito; Yali Zhang; Xiaoying Qiao; Lara Reyelt; Vikram Paruchuri; Gavin R Schnitzler; Kevin J Morine; Shiva K Annamalai; Courtney Bogins; Peter S Natov; Robert Pedicini; Catalina Breton; Andrew Mullin; Emily E Mackey; Ayan Patel; Ethan Rowin; Iris Z Jaffe; Richard H Karas; Navin K Kapur
Journal:  J Am Coll Cardiol       Date:  2018-07-31       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.